Menopausal Women Turn to Unregulated Peptides as DIY Hormone Therapy
A growing number of women are bypassing traditional medical channels to use experimental, unapproved peptides for managing menopause and perimenopause symptoms. Driven by social media influencers and a lack of effective conventional treatments, these individuals often self-administer injectable compounds like retatrutide and BPC-157. While many report significant improvements in energy, mood, and weight, the practice carries substantial risks, including incorrect dosing, adverse physical reactions, and exposure to counterfeit products. Medical experts warn that the lack of regulation and clinical oversight makes this a dangerous 'gray market' trend.